Guttman-McCabe Christopher bought ATEX
June 15, 2026 · Form 4 insider transaction
Guttman-McCabe Christopher bought 50,876 shares of Anterix Inc. at $34.40 per share, a transaction worth $1.75M. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
50,876
Price
$34.40
Total value
$1.75M
InsiderGuttman-McCabe Christopher
Role—
CompanyAnterix Inc. (ATEX)
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJune 15, 2026
Filing dateJune 17, 2026
Shares owned after117,018
OwnershipDirect
10b5-1 planNo
AmendedNo